Toll-like receptor (TLR) signaling relies on Toll/interleukin-1 receptor homology (TIR) domain-containing adaptor proteins that recruit downstream signaling molecules to generate tailored immune responses. In addition, the palmitoylated transmembrane adaptor protein family member Scimp acts as a non-TIR-containing adaptor protein in macrophages, scaffolding the Src family kinase Lyn to enable TLR phosphorylation and proinflammatory signaling responses. Here we report the existence of a smaller, naturally occurring translational variant of Scimp (Scimp TV1), which is generated through leaky scanning and translation at a downstream methionine. Scimp TV1 also scaffolds Lyn, but in contrast to full-length Scimp, it is basally rather than lipopolysaccharide (LPS)-inducibly phosphorylated. Macrophages from mice that selectively express Scimp TV1, but not full-length Scimp, have impaired sustained LPS-inducible cytokine responses. Furthermore, in granulocyte macrophage colony-stimulating factor-derived myeloid cells that express high levels of Scimp, selective overexpression of Scimp TV1 enhances CpG DNA-inducible cytokine production. Unlike full-length Scimp that localizes to the cell surface and filopodia, Scimp TV1 accumulates in intracellular compartments, particularly the Golgi. Moreover, this variant of Scimp is not inducibly phosphorylated in response to CpG DNA, suggesting that it may act via an indirect mechanism to enhance TLR9 responses. Our findings thus reveal the use of alternative translation start sites as a previously unrecognized mechanism for diversifying TLR responses in the innate immune system.

Friedrich Miescher Institute for Biomedical Research Basel Switzerland

Institute for Molecular Bioscience IMB Centre for Inflammation and Disease Research and Australian Infectious Diseases Research Centre The University of Queensland Brisbane QLD Australia

Laboratory of Leukocyte Signaling Institute of Molecular Genetics of the Czech Academy of Sciences Prague Czech Republic

See more in PubMed

Mu X, Li Y, Fan GC. Tissue‐resident macrophages in the control of infection and resolution of inflammation. Shock 2021; 55: 14–23. PubMed PMC

Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140: 805–820. PubMed

Schaefer L. Complexity of danger: the diverse nature of damage‐associated molecular patterns. J Biol Chem 2014; 289: 35237–35245. PubMed PMC

Kawasaki T, Kawai T. Toll‐like receptor signaling pathways. Front Immunol 2014; 5: 1–8. PubMed PMC

Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll‐like receptor 4 (TLR4)‐deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749. PubMed

Park BS, Lee J‐O. Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med 2013; 45: e66. PubMed PMC

Fitzgerald KA, Palsson‐McDermott EM, Bowie AG, et al. Mal (MyD88‐adapter‐like) is required for Toll‐like receptor‐4 signal transduction. Nature 2001; 413: 78–83. PubMed

Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88‐deficient mice to endotoxin. Immunity 1999; 11: 115–122. PubMed

Kagan JC, Medzhitov R. Phosphoinositide‐mediated adaptor recruitment controls Toll‐like receptor signaling. Cell 2006; 125: 943–955. PubMed

O'Neill LAJ, Dunne A, Edjeback M, Gray P, Jefferies C, Wietek C. Mal and MyD88: adapter proteins involved in signal transduction by Toll‐like receptors. J Endotoxin Res 2003; 9: 55–59. PubMed

Motshwene PG, Moncrieffe MC, Grossmann JG, et al. An oligomeric signaling platform formed by the Toll‐like receptor signal transducers MyD88 and IRAK‐4. J Biol Chem 2009; 284: 25404–25411. PubMed PMC

Balka KR, De Nardo D. Understanding early TLR signaling through the Myddosome. J Leukoc Biol 2019; 105: 339–351. PubMed

Hemmi H, Takeuchi O, Kawai T, et al. A Toll‐like receptor recognizes bacterial DNA. Nature 2000; 408: 740–745. PubMed

Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88‐independent toll‐like receptor signaling pathway. Science 2003; 301: 640–643. PubMed

Häcker H, Vabulas RM, Takeuchi O, Hoshino K, Akira S, Wagner H. Immune cell activation by bacterial Cpg‐DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor‐associated factor (Traf)6. J Exp Med 2000; 192: 595–600. PubMed PMC

Lee BL, Moon JE, Shu JH, et al. UNC93B1 mediates differential trafficking of endosomal TLRs. eLife 2013; 2: e00291. PubMed PMC

Marongiu L, Gornati L, Artuso I, Zanoni I, Granucci F. Below the surface: the inner lives of TLR4 and TLR9. J Leukoc Biol 2019; 106: 147–160. PubMed PMC

Stepanek O, Draber P, Horejsi V. Palmitoylated transmembrane adaptor proteins in leukocyte signaling. Cell Signal 2014; 26: 895–902. PubMed

Chattopadhyay S, Sen GC. Tyrosine phosphorylation in Toll‐like receptor signaling. Cytokine Growth Factor Rev 2014; 25: 533–541. PubMed PMC

Medvedev AE, Piao W, Shoenfelt J, et al. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J Biol Chem 2007; 282: 16042–16053. PubMed PMC

Smolinska MJ, Horwood NJ, Page TH, Smallie T, Foxwell BMJ. Chemical inhibition of Src family kinases affects major LPS‐activated pathways in primary human macrophages. Mol Immunol 2008; 45: 990–1000. PubMed

Draber P, Vonkova I, Stepanek O, et al. SCIMP, a transmembrane adaptor protein involved in major histocompatibility complex class II signaling. Mol Cell Biol 2011; 31: 4550–4562. PubMed PMC

Curson JEB, Luo L, Sweet MJ, Stow JL. pTRAPs: Transmembrane adaptors in innate immune signaling. J Leukoc Biol 2018; 103: 1011–1019. PubMed

Kralova J, Fabisik M, Pokorna J, Skopcova T, Malissen B, Brdicka T. The transmembrane adaptor protein scimp facilitates sustained dectin‐1 signaling in dendritic cells. J Biol Chem 2016; 291: 16530–16540. PubMed PMC

Luo L, Bokil NJ, Wall AA, et al. SCIMP is a transmembrane non‐TIR TLR adaptor that promotes proinflammatory cytokine production from macrophages. Nat Commun 2017; 8: 14133. PubMed PMC

Luo L, Tong SJ, Wall AA, Khromykh T, Sweet MJ, Stow JL. Development of SH2 probes and pull‐down assays to detect pathogen‐induced, site‐specific tyrosine phosphorylation of the TLR adaptor SCIMP. Immunol Cell Biol 2017; 95: 564–570. PubMed

Luo L, Curson JEB, Liu L, et al. SCIMP is a universal Toll‐like receptor adaptor in macrophages. J Leukoc Biol 2020; 107: 251–262. PubMed

Lee Y, Rio DC. Mechanisms and regulation of alternative pre‐mRNA splicing. Annu Rev Biochem 2015; 84: 291–323. PubMed PMC

Wells CA, Chalk AM, Forrest A, et al. Alternate transcription of the Toll‐like receptor signaling cascade. Genome Biol 2006; 7: R10. PubMed PMC

Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R, Tschopp J. Inhibition of interleukin 1 receptor/Toll‐like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK‐4. J Exp Med 2003; 197: 263–268. PubMed PMC

Hardy MP, O'Neill LA. The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory. J Biol Chem 2004; 279: 27699–27708. PubMed

Bazykin GA, Kochetov AV. Alternative translation start sites are conserved in eukaryotic genomes. Nucleic Acids Res 2011; 39: 567–577. PubMed PMC

Kozak M. Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 2005; 361: 13–37. PubMed

Leissring MA, Farris W, Wu X, et al. Alternative translation initiation generates a novel isoform of insulin‐degrading enzyme targeted to mitochondria. Biochem J 2004; 383: 439–446. PubMed PMC

Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 1987; 196: 947–950. PubMed

Chum T, Glatzová D, Kvíčalová Z, Malínský J, Brdička T, Cebecauer M. The role of palmitoylation and transmembrane domain in sorting of transmembrane adaptor proteins. J Cell Sci 2016; 129: 95–107. PubMed

Seeley JJ, Ghosh S. Molecular mechanisms of innate memory and tolerance to LPS. J Leukoc Biol 2017; 101: 107–119. PubMed

Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL, Kim Y‐M. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 2007; 177: 265–275. PubMed PMC

Ban T, Sato GR, Nishiyama A, et al. Lyn kinase suppresses the transcriptional activity of IRF5 in the TLR‐MyD88 pathway to restrain the development of autoimmunity. Immunity 2016; 45: 319–332. PubMed

Icer MA, Gezmen‐Karadag M. The multiple functions and mechanisms of osteopontin. Clin Biochem 2018; 59: 17–24. PubMed

Shinohara ML, Kim H‐J, Kim J‐H, Garcia VA, Cantor H. Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc Natl Acad Sci 2008; 105: 7235–7239. PubMed PMC

Rollinger‐Holzinger I, Eibl B, Pauly M, et al. LST1: a gene with extensive alternative splicing and immunomodulatory function. J Immunol 2000; 164: 3169. PubMed

Draber P, Stepanek O, Hrdinka M, et al. LST1/A is a myeloid leukocyte‐specific transmembrane adaptor protein recruiting protein tyrosine phosphatases SHP‐1 and SHP‐2 to the plasma membrane. J Biol Chem 2012; 287: 22812–22821. PubMed PMC

De Baey A, Fellerhoff B, Maier S, Martinozzi S, Weidle U, Weiss EH. Complex expression pattern of the TNF region gene LST1 through differential regulation, initiation, and alternative splicing. Genomics 1997; 45: 591–600. PubMed

Skabkin MA, Skabkina OV, Hellen CUT, Pestova TV. Reinitiation and other unconventional posttermination events during eukaryotic translation. Mol Cell 2013; 51: 249–264. PubMed PMC

Jackson RJ, Hellen CU, Pestova TV. Termination and post‐termination events in eukaryotic translation. Adv Protein Chem Struct Biol 2012; 86: 45–93. PubMed

Benitez‐Cantos MS, Yordanova MM, O'Connor PBF, et al. Translation initiation downstream from annotated start codons in human mRNAs coevolves with the Kozak context. Genome Res 2020; 30: 974–984. PubMed PMC

Morita S, Kojima T, Kitamura T. Plat‐E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000; 7: 1063–1066. PubMed

Pear WS, Miller JP, Xu L, et al. Efficient and rapid induction of a chronic myelogenous leukemia‐like myeloproliferative disease in mice receiving P210 bcr/abl‐transduced bone marrow. Blood 1998; 92: 3780–3792. PubMed